Testing body-water measurements in people with stomach cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses a painless machine to measure your body composition (mainly fluid and muscle) using bioelectrical impedance. It’s looking at people with stage II–III stomach cancer who are receiving standard “multi-treatment” care, to see whether these measurements are useful during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have confirmed stomach cancer (gastric adenocarcinoma or undifferentiated carcinoma)
- Your cancer is stage II or III (not early stage)
- Your cancer team plans multi-treatment care (for example, surgery and/or other standard treatments)
- You do not have cancer that has spread to distant organs (no metastasis)
- You can safely get the scan: no implanted heart devices, certain metal implants, and not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well patient-recorded measurements can be used during cancer care around the time of curative-intent surgery or chemotherapy before surgery. It may help improve monitoring and decision-making during treatment.
This study tests a way to spot malnutrition early in cancer patients and older adults who are in the hospital. It aims to help doctors catch and treat nutrition problems sooner.
This trial tests a combination of whole-body muscle stimulation and nutritional therapy to help recovery after surgery for cancers of the digestive system. It aims to improve strength and well-being.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This trial studies whether doing a structured exercise program and receiving enteral (tube) nutrition after gastric cancer surgery can improve survival. It focuses on people with stage Ib to stage IIIc stomach cancer who have had standard surgery and have not had chemo or radiation before.
This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.